| Value | ₹10.46 Cr |
|---|
BSE filing, NSE: SHUKRAPHAR. Summary written from the filing by ALFA Finder's alert engine.
Shukra Pharmaceuticals Ltd: key numbers
- Share price
- ₹79.88
- Market cap
- ₹3,535 Cr
- Revenue (annual)
- ₹56.73 Cr
- Net profit (annual)
- ₹22.06 Cr
- P/E (TTM)
- 104.0×Sector 41.3×
- Promoter holding
- 51.15%+0.19% QoQ
- FII holding
- 0.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shukra Pharmaceuticals Ltd
All →Shukra Pharmaceuticals Q2 FY27 Results: Net Profit ₹12.7 Cr, Up 429.2% YoY
Shukra Pharmaceuticals Ltd reported revenue from operations of ₹44.2 Cr (+649.2% YoY) and net profit of ₹12.7 Cr (+429.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹12.7 Cr · +429.2% YoY
Shukra Pharmaceuticals Board Meeting Date
Shukra Medtech Limited has scheduled a board meeting on November 3, 2026, to consider and approve its unaudited financial results for the quarter ended September 2026.
Shukra Pharmaceuticals Other Announcement
Shukra Medtech submitted a revised CA certificate to NSE for its name and symbol change application. The filing requests final exchange approval for the corporate rename.
Shukra Pharmaceuticals Other Announcement
Shukra Pharmaceuticals Limited has submitted the certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Shukra Pharmaceuticals Capital Structure Change
Shukra Pharmaceuticals allotted 17.35 lakh equity shares upon warrant conversion to promoters. The exercise raised Rs. 4.63 Crore, increasing the paid-up capital.
- Value
- ₹4.63 Cr
Shukra Pharmaceuticals Price Movement Clarification
Shukra Pharmaceuticals clarified that the recent share price movement is market-driven. The company confirmed no undisclosed, price-sensitive information exists.
Other other announcement announcements
All →Sattva Sukun Lifecare Other Announcement
Tavexia Lifecare Ltd board approved changing its RTA from Niche Technologies to Skyline Financial Services. Niche continues until data transition and depository confirmations are complete.
Gabion Technologies India Other Announcement
Gabion Technologies re-appointed VRSK & Associates as internal auditor, effective 4 November 2026, for a one-month term. Routine auditor re-appointment with no material business impact.
Lippi Systems Other Announcement
Nilkanth Resources (formerly Lippi Systems) reports no deviation in the use of preferential warrant proceeds. Rs 9.24 Crore, being 25% of the warrant consideration, was received and fully utilised.
- Value
- ₹9.24 Cr
All Time Plastics Other Announcement
All Time Plastics' RTA, KFIN Technologies, moves its correspondence office to Hyderabad from December 1, 2026. Shareholder communications must use the new address from that date.
Krishna Institute of Medical Sciences Other Announcement
KIMS's CARE Ratings monitoring report shows ₹1,311.81 crore of the ₹1,476.45 crore QIP proceeds utilised till Q2 FY27. No deviation from the stated objects was reported.
Transchem Other Announcement
Transchem's monitoring agency reports no deviation in warrant proceeds utilisation for the quarter ended September 2026. No material facts were flagged.